Axon Enterprise, Inc (NASDAQ:AXON) Stock Has Average Target Price of $688.38 According to Analysts

Key Points

• Analysts remain broadly positive: Axon has a “Moderate Buy” consensus from 17 analysts—14 buys and three holds—with an average 12-month price target of $688.38.
• Revenue grew, but results and guidance disappointed: Q3 revenue rose 27.8% year over year to about $909 million, while EPS and revenue missed estimates; the company’s Q4 and full-year revenue outlooks also came in below consensus.
• Axon invested an additional $1.2 billion in Skydio, bringing its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada, strengthening its drone strategy while requiring significant capital.

Axon Enterprise, Inc (NASDAQ:AXON - Get Free Report) has been given an average recommendation of "Moderate Buy" by the seventeen analysts that are covering the firm, Marketbeat Ratings reports. Three analysts have rated the stock with a hold rating and fourteen have issued a buy rating on the company. The average 12-month price objective among analysts that have issued a report on the stock in the last year is $688.38.

Several equities analysts have weighed in on the stock. Royal Bank Of Canada reiterated an "outperform" rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Weiss Ratings restated a "hold (c-)" rating on shares of Axon Enterprise in a report on Tuesday. Citigroup reaffirmed a "market outperform" rating on shares of Axon Enterprise in a research report on Monday. Northcoast Research raised their target price on Axon Enterprise from $650.00 to $680.00 and gave the stock a "buy" rating in a research report on Tuesday, August 11th. Finally, Piper Sandler lowered their price target on Axon Enterprise from $732.00 to $561.00 and set an "overweight" rating on the stock in a report on Tuesday, October 20th.

Axon Enterprise Stock Performance

Axon Enterprise stock opened at $382.56 on Friday. The stock's 50 day moving average price is $447.49 and its 200 day moving average price is $476.73. The firm has a market capitalization of $31.08 billion, a PE ratio of 158.74, a price-to-earnings-growth ratio of 8.06 and a beta of 1.48. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. Axon Enterprise has a one year low of $339.01 and a one year high of $665.07.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The biotechnology company reported $1.72 EPS for the quarter, missing analysts' consensus estimates of $1.89 by ($0.17). Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%. The company had revenue of $908.55 million for the quarter, compared to the consensus estimate of $934.33 million. During the same quarter in the previous year, the company earned $1.17 earnings per share. Axon Enterprise's quarterly revenue was up 27.8% compared to the same quarter last year. As a group, sell-side analysts expect that Axon Enterprise will post 2.10 EPS for the current fiscal year.

Insiders Place Their Bets

In other Axon Enterprise news, President Joshua Isner sold 16,775 shares of the firm's stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $574.43, for a total transaction of $9,636,063.25. Following the completion of the sale, the president directly owned 296,974 shares in the company, valued at approximately $170,590,774.82. This trade represents a 5.35% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 10,000 shares of Axon Enterprise stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the transaction, the chief executive officer directly owned 3,118,012 shares in the company, valued at approximately $1,587,036,927.88. This trade represents a 0.32% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 37,397 shares of company stock valued at $21,234,034 in the last 90 days. Insiders own 4.20% of the company's stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. CENTRAL TRUST Co grew its holdings in Axon Enterprise by 3,086.6% during the third quarter. CENTRAL TRUST Co now owns 147,028 shares of the biotechnology company's stock valued at $62,122,000 after purchasing an additional 142,414 shares during the period. Three Bridge Wealth Advisors LLC bought a new stake in Axon Enterprise in the third quarter valued at approximately $41,000. King Luther Capital Management Corp raised its holdings in Axon Enterprise by 1,731.8% in the third quarter. King Luther Capital Management Corp now owns 116,539 shares of the biotechnology company's stock worth $49,240,000 after purchasing an additional 110,177 shares during the period. New Mexico Educational Retirement Board raised its holdings in Axon Enterprise by 5,332.1% in the third quarter. New Mexico Educational Retirement Board now owns 213,807 shares of the biotechnology company's stock worth $90,338,000 after purchasing an additional 209,871 shares during the period. Finally, Maryland State Retirement & Pension System raised its holdings in Axon Enterprise by 6,258.0% in the third quarter. Maryland State Retirement & Pension System now owns 260,804 shares of the biotechnology company's stock worth $110,195,000 after purchasing an additional 256,702 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Trending Headlines about Axon Enterprise

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Axon reported record Q3 revenue of $909 million, up 28% year over year, and returned to net income. Adjusted EBITDA rose 33% to $236 million. Axon Q3 results
• Positive Sentiment: Growth in newer offerings was strong: Drone as First Responder software and services revenue grew 43%, Platform Solutions revenue climbed 106%, and AI annual recurring revenue exceeded $100 million. Axon Q3 results
• Positive Sentiment: Axon invested an additional $1.2 billion in Skydio, raising its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The deal could strengthen Axon’s drone-response offering, though it requires substantial capital. Axon Skydio investment
• Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of about $909 million both missed analyst estimates, despite solid year-over-year growth. Q3 earnings and revenue miss
• Negative Sentiment: Axon’s Q4 revenue outlook of $990 million–$1.0 billion was below the roughly $1.1 billion consensus, while its full-year 2026 revenue outlook of $3.6 billion also trailed expectations of about $3.7 billion. Revenue outlook and Skydio investment
• Negative Sentiment: Zacks Research downgraded Axon from “strong buy” to “hold.” A lawsuit over the company’s AI-powered license-plate-reader network also presents potential legal uncertainty. License plate reader lawsuit

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and connected products for public safety organizations. The company's portfolio includes TASER conducted-energy weapons, body-worn cameras, in-car cameras, and related hardware designed to support law enforcement, corrections, security, and other emergency-response professionals.

Axon also provides cloud-based software for managing digital evidence, records, workflows, real-time operations, investigations, and communications. Its platform is intended to connect hardware, software, and services across the public-safety ecosystem, helping agencies collect, store, analyze, and share operational information.

The company was founded in 1993 as TASER International by Rick Smith and Tom Smith and adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into a broader technology platform.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.